BNP Paribas Financial Markets’s Caribou Biosciences CRBU Stock Holding History

BNP Paribas Financial Markets’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$125K	Buy	70,896 +68,751	+3,205%	+$136K	﹤0.01%	4432
2026 Q1	$4.08K	Buy	2,145 +267	+14%	+$458	﹤0.01%	5342
2025 Q4	$2.99K	Buy	1,878 +2	+0.1%	+$4	﹤0.01%	5314
2025 Q3	$4.37K	Sell	1,876 -17,487	-90%	-$33K	﹤0.01%	5104
2025 Q2	$24.4K	Sell	19,363 -20,278	-51%	-$19.9K	﹤0.01%	4515
2025 Q1	$36.2K	Buy	39,641 +31,064	+362%	+$40.4K	﹤0.01%	4384
2024 Q4	$13.6K	Buy	+8,577	New	+$17.2K	﹤0.01%	4796
2022 Q4	–	Sell	-83,101	Closed	-$877K	–	4171
2022 Q3	$877K	Buy	+83,101	New	+$774K	﹤0.01%	2596

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Financial Markets's CRBU Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Caribou Biosciences (CRBU) stake by 3,205% in Q2 2026, buying an estimated $136K and bringing the position to 70,896 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #4432.

BNP Paribas Financial Markets first reported a position in CRBU in Q3 2022 and has held it in 8 quarters since. The position peaked at $877K in Q3 2022. 101 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

BNP Paribas Financial Markets held 70,896 shares of Caribou Biosciences worth $125K as of Q2 2026.
BNP Paribas Financial Markets bought 68,751 Caribou Biosciences shares in Q2 2026, an estimated $136K.
Caribou Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4432 holding.
BNP Paribas Financial Markets first reported a position in Caribou Biosciences in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's Caribou Biosciences position peaked at $877K in Q3 2022.
101 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.